APO Research
Talk to an analyst

APO RESEARCH · REPORT

Venlafaxine Preparations

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Venlafaxine Preparations Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025196 pages

Choose your research edition.

Industry ResearchVenlafaxine Preparations Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Venlafaxine Preparations Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Venlafaxine Preparations Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Venlafaxine Preparations Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Venlafaxine Preparations Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Venlafaxine Preparations market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Venlafaxine Preparations is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Venlafaxine Preparations is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Venlafaxine Preparations is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Venlafaxine Preparations is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Venlafaxine Preparations include Alembic, Dr. Reddy's Laboratories, Granules, Macleods Pharmaceuticals, Orbion Pharmaceuticals, Pfizer, Teva, Zydus and Beijing Foyou Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Venlafaxine Preparations market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Venlafaxine Preparations and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Venlafaxine Preparations sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Venlafaxine Preparations market size, projected growth trends, production technologies, key applications, and end-use industries.

Venlafaxine Preparations Segment by Company

Alembic

Dr. Reddy's Laboratories

Granules

Macleods Pharmaceuticals

Orbion Pharmaceuticals

Pfizer

Teva

Zydus

Beijing Foyou Pharma

Changzhou Siyao Pharmaceuticals

Chengdu Brilliant Pharmaceutical

Chengdu Kanghong Pharmaceutical

ApicHope Pharmaceutical

Sinopharm Group

Hainan Herui Pharmaceutical

Hefei Lifeon Pharmaceutical

Luye Pharma

CSPC Ouyi Pharmaceutical

YaoPharma

Venlafaxine Preparations Segment by Type

Capsules

Tablets

Venlafaxine Preparations Segment by Application

Generalized Anxiety Disorder

Social Anxiety Disorder and Panic Disorder

Depression

Other

Venlafaxine Preparations Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Venlafaxine Preparations market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Venlafaxine Preparations and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Venlafaxine Preparations.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Venlafaxine Preparations market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Venlafaxine Preparations manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Venlafaxine Preparations in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Venlafaxine Preparations in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Venlafaxine Preparations Industry Trends Table 2. Venlafaxine Preparations Industry Drivers Table 3. Venlafaxine Preparations Industry Opportunities and Challenges Table 4. Venlafaxine Preparations Industry Restraints Table 5. Global Venlafaxine Preparations Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Venlafaxine Preparations Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Venlafaxine Preparations Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Venlafaxine Preparations Sales Market Share by Manufacturers Table 9. Global Venlafaxine Preparations Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Venlafaxine Preparations Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Venlafaxine Preparations Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Venlafaxine Preparations Manufacturers, Product Type & Application Table 13. Global Venlafaxine Preparations Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Venlafaxine Preparations by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Capsules Table 17. Major Manufacturers of Tablets Table 18. Global Venlafaxine Preparations Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Venlafaxine Preparations Sales by Type (2021-2026) & (K Units) Table 20. Global Venlafaxine Preparations Sales by Type (2027-2032) & (K Units) Table 21. Global Venlafaxine Preparations Sales Market Share by Type (2021-2026) Table 22. Global Venlafaxine Preparations Sales Market Share by Type (2027-2032) Table 23. Global Venlafaxine Preparations Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Venlafaxine Preparations Revenue by Type (2021-2026) & (K Units) Table 25. Global Venlafaxine Preparations Revenue by Type (2027-2032) & (K Units) Table 26. Global Venlafaxine Preparations Revenue Market Share by Type (2021-2026) Table 27. Global Venlafaxine Preparations Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Generalized Anxiety Disorder Table 29. Major Manufacturers of Social Anxiety Disorder and Panic Disorder Table 30. Major Manufacturers of Depression Table 31. Major Manufacturers of Other Table 32. Global Venlafaxine Preparations Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Venlafaxine Preparations Sales by Application (2021-2026) & (K Units) Table 34. Global Venlafaxine Preparations Sales by Application (2027-2032) & (K Units) Table 35. Global Venlafaxine Preparations Sales Market Share by Application (2021-2026) Table 36. Global Venlafaxine Preparations Sales Market Share by Application (2027-2032) Table 37. Global Venlafaxine Preparations Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Venlafaxine Preparations Revenue by Application (2021-2026) & (K Units) Table 39. Global Venlafaxine Preparations Revenue by Application (2027-2032) & (K Units) Table 40. Global Venlafaxine Preparations Revenue Market Share by Application (2021-2026) Table 41. Global Venlafaxine Preparations Revenue Market Share by Application (2027-2032) Table 42. Global Venlafaxine Preparations Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Venlafaxine Preparations Sales by Region (2021-2026) & (K Units) Table 44. Global Venlafaxine Preparations Sales Market Share by Region (2021-2026) Table 45. Global Venlafaxine Preparations Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Venlafaxine Preparations Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Venlafaxine Preparations Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Venlafaxine Preparations Sales by Country (2021-2026) & (K Units) Table 49. North America Venlafaxine Preparations Sales by Country (2027-2032) & (K Units) Table 50. Europe Venlafaxine Preparations Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Venlafaxine Preparations Sales by Country (2021-2026) & (K Units) Table 52. Europe Venlafaxine Preparations Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Venlafaxine Preparations Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Venlafaxine Preparations Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Venlafaxine Preparations Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Venlafaxine Preparations Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Venlafaxine Preparations Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Venlafaxine Preparations Sales by Country (2027-2032) & (K Units) Table 59. Global Venlafaxine Preparations Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Venlafaxine Preparations Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Venlafaxine Preparations Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Venlafaxine Preparations Revenue Market Share by Region (2021-2026) Table 63. Global Venlafaxine Preparations Revenue Market Share by Region (2027-2032) Table 64. Alembic Company Information Table 65. Alembic Business Overview Table 66. Alembic Venlafaxine Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Alembic Venlafaxine Preparations Product Portfolio Table 68. Alembic Recent Development Table 69. Dr. Reddy's Laboratories Company Information Table 70. Dr. Reddy's Laboratories Business Overview Table 71. Dr. Reddy's Laboratories Venlafaxine Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Dr. Reddy's Laboratories Venlafaxine Preparations Product Portfolio Table 73. Dr. Reddy's Laboratories Recent Development Table 74. Granules Company Information Table 75. Granules Business Overview Table 76. Granules Venlafaxine Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Granules Venlafaxine Preparations Product Portfolio Table 78. Granules Recent Development Table 79. Macleods Pharmaceuticals Company Information Table 80. Macleods Pharmaceuticals Business Overview Table 81. Macleods Pharmaceuticals Venlafaxine Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Macleods Pharmaceuticals Venlafaxine Preparations Product Portfolio Table 83. Macleods Pharmaceuticals Recent Development Table 84. Orbion Pharmaceuticals Company Information Table 85. Orbion Pharmaceuticals Business Overview Table 86. Orbion Pharmaceuticals Venlafaxine Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Orbion Pharmaceuticals Venlafaxine Preparations Product Portfolio Table 88. Orbion Pharmaceuticals Recent Development Table 89. Pfizer Company Information Table 90. Pfizer Business Overview Table 91. Pfizer Venlafaxine Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Pfizer Venlafaxine Preparations Product Portfolio Table 93. Pfizer Recent Development Table 94. Teva Company Information Table 95. Teva Business Overview Table 96. Teva Venlafaxine Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Teva Venlafaxine Preparations Product Portfolio Table 98. Teva Recent Development Table 99. Zydus Company Information Table 100. Zydus Business Overview Table 101. Zydus Venlafaxine Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Zydus Venlafaxine Preparations Product Portfolio Table 103. Zydus Recent Development Table 104. Beijing Foyou Pharma Company Information Table 105. Beijing Foyou Pharma Business Overview Table 106. Beijing Foyou Pharma Venlafaxine Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Beijing Foyou Pharma Venlafaxine Preparations Product Portfolio Table 108. Beijing Foyou Pharma Recent Development Table 109. Changzhou Siyao Pharmaceuticals Company Information Table 110. Changzhou Siyao Pharmaceuticals Business Overview Table 111. Changzhou Siyao Pharmaceuticals Venlafaxine Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Changzhou Siyao Pharmaceuticals Venlafaxine Preparations Product Portfolio Table 113. Changzhou Siyao Pharmaceuticals Recent Development Table 114. Chengdu Brilliant Pharmaceutical Company Information Table 115. Chengdu Brilliant Pharmaceutical Business Overview Table 116. Chengdu Brilliant Pharmaceutical Venlafaxine Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Chengdu Brilliant Pharmaceutical Venlafaxine Preparations Product Portfolio Table 118. Chengdu Brilliant Pharmaceutical Recent Development Table 119. Chengdu Kanghong Pharmaceutical Company Information Table 120. Chengdu Kanghong Pharmaceutical Business Overview Table 121. Chengdu Kanghong Pharmaceutical Venlafaxine Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Chengdu Kanghong Pharmaceutical Venlafaxine Preparations Product Portfolio Table 123. Chengdu Kanghong Pharmaceutical Recent Development Table 124. ApicHope Pharmaceutical Company Information Table 125. ApicHope Pharmaceutical Business Overview Table 126. ApicHope Pharmaceutical Venlafaxine Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. ApicHope Pharmaceutical Venlafaxine Preparations Product Portfolio Table 128. ApicHope Pharmaceutical Recent Development Table 129. Sinopharm Group Company Information Table 130. Sinopharm Group Business Overview Table 131. Sinopharm Group Venlafaxine Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Sinopharm Group Venlafaxine Preparations Product Portfolio Table 133. Sinopharm Group Recent Development Table 134. Hainan Herui Pharmaceutical Company Information Table 135. Hainan Herui Pharmaceutical Business Overview Table 136. Hainan Herui Pharmaceutical Venlafaxine Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Hainan Herui Pharmaceutical Venlafaxine Preparations Product Portfolio Table 138. Hainan Herui Pharmaceutical Recent Development Table 139. Hefei Lifeon Pharmaceutical Company Information Table 140. Hefei Lifeon Pharmaceutical Business Overview Table 141. Hefei Lifeon Pharmaceutical Venlafaxine Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Hefei Lifeon Pharmaceutical Venlafaxine Preparations Product Portfolio Table 143. Hefei Lifeon Pharmaceutical Recent Development Table 144. Luye Pharma Company Information Table 145. Luye Pharma Business Overview Table 146. Luye Pharma Venlafaxine Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. Luye Pharma Venlafaxine Preparations Product Portfolio Table 148. Luye Pharma Recent Development Table 149. CSPC Ouyi Pharmaceutical Company Information Table 150. CSPC Ouyi Pharmaceutical Business Overview Table 151. CSPC Ouyi Pharmaceutical Venlafaxine Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 152. CSPC Ouyi Pharmaceutical Venlafaxine Preparations Product Portfolio Table 153. CSPC Ouyi Pharmaceutical Recent Development Table 154. YaoPharma Company Information Table 155. YaoPharma Business Overview Table 156. YaoPharma Venlafaxine Preparations Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 157. YaoPharma Venlafaxine Preparations Product Portfolio Table 158. YaoPharma Recent Development Table 159. Key Raw Materials Table 160. Raw Materials Key Suppliers Table 161. Venlafaxine Preparations Distributors List Table 162. Venlafaxine Preparations Customers List Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources Table 166. Primary Sources List of Figures Figure 1. Venlafaxine Preparations Product Image Figure 2. Global Venlafaxine Preparations Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Venlafaxine Preparations Market Size (2021-2032) & (US$ Million) Figure 4. Global Venlafaxine Preparations Sales (2021-2032) & (K Units) Figure 5. Global Venlafaxine Preparations Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Venlafaxine Preparations Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Capsules Image Figure 9. Tablets Image Figure 10. Global Venlafaxine Preparations Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Venlafaxine Preparations Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Venlafaxine Preparations Sales Market Share by Type (2021-2032) Figure 13. Global Venlafaxine Preparations Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Venlafaxine Preparations Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Venlafaxine Preparations Revenue Market Share by Type (2021-2032) Figure 16. Generalized Anxiety Disorder Image Figure 17. Social Anxiety Disorder and Panic Disorder Image Figure 18. Depression Image Figure 19. Other Image Figure 20. Global Venlafaxine Preparations Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Venlafaxine Preparations Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Venlafaxine Preparations Sales Market Share by Application (2021-2032) Figure 23. Global Venlafaxine Preparations Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Venlafaxine Preparations Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Venlafaxine Preparations Revenue Market Share by Application (2021-2032) Figure 26. North America Venlafaxine Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Venlafaxine Preparations Sales Market Share by Country (2021-2032) Figure 28. U.S. Venlafaxine Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Venlafaxine Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Venlafaxine Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Venlafaxine Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Venlafaxine Preparations Sales Market Share by Country (2021-2032) Figure 33. Germany Venlafaxine Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Venlafaxine Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Venlafaxine Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Venlafaxine Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Venlafaxine Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Venlafaxine Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Venlafaxine Preparations Sales Market Share by Country (2021-2032) Figure 40. China Venlafaxine Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Venlafaxine Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Venlafaxine Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Venlafaxine Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Venlafaxine Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Venlafaxine Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Venlafaxine Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Venlafaxine Preparations Sales Market Share by Country (2021-2032) Figure 48. Brazil Venlafaxine Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Venlafaxine Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Venlafaxine Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Venlafaxine Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Venlafaxine Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Venlafaxine Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Venlafaxine Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Venlafaxine Preparations Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Venlafaxine Preparations Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Venlafaxine Preparations Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Venlafaxine Preparations Revenue (2021-2032) & (US$ Million) Figure 59. North America Venlafaxine Preparations Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Venlafaxine Preparations Revenue (2021-2032) & (US$ Million) Figure 61. Europe Venlafaxine Preparations Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Venlafaxine Preparations Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Venlafaxine Preparations Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Venlafaxine Preparations Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Venlafaxine Preparations Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Venlafaxine Preparations Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Venlafaxine Preparations Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Capsules
  • Tablets
Applications
  • Generalized Anxiety Disorder
  • Social Anxiety Disorder and Panic Disorder
  • Depression
  • Other
Companies covered
  • Alembic
  • Dr. Reddy's Laboratories
  • Granules
  • Macleods Pharmaceuticals
  • Orbion Pharmaceuticals
  • Pfizer
  • Teva
  • Zydus
  • Beijing Foyou Pharma
  • Changzhou Siyao Pharmaceuticals
  • Chengdu Brilliant Pharmaceutical
  • Chengdu Kanghong Pharmaceutical
  • ApicHope Pharmaceutical
  • Sinopharm Group
  • Hainan Herui Pharmaceutical
  • Hefei Lifeon Pharmaceutical
  • Luye Pharma
  • CSPC Ouyi Pharmaceutical
  • YaoPharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Venlafaxine Preparations Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Venlafaxine Preparations Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Venlafaxine Preparations Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Venlafaxine Preparations Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Venlafaxine Preparations Market Dynamics
  1. 2.1 Venlafaxine Preparations Industry Trends
  2. 2.2 Venlafaxine Preparations Industry Drivers
  3. 2.3 Venlafaxine Preparations Industry Opportunities and Challenges
  4. 2.4 Venlafaxine Preparations Industry Restraints
3 Venlafaxine Preparations Market by Manufacturers
  1. 3.1 Global Venlafaxine Preparations Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Venlafaxine Preparations Sales by Manufacturers (2021-2026)
  3. 3.3 Global Venlafaxine Preparations Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Venlafaxine Preparations Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Venlafaxine Preparations Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Venlafaxine Preparations Manufacturers, Product Type & Application
  7. 3.7 Global Venlafaxine Preparations Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Venlafaxine Preparations Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Venlafaxine Preparations Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Venlafaxine Preparations Tier 1, Tier 2, and Tier 3
4 Venlafaxine Preparations Market by Type
  1. 4.1 Venlafaxine Preparations Type Introduction
  2. 4.1.1 Capsules
  3. 4.1.2 Tablets
  4. 4.2 Global Venlafaxine Preparations Sales by Type
  5. 4.2.1 Global Venlafaxine Preparations Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Venlafaxine Preparations Sales by Type (2021-2032)
  7. 4.2.3 Global Venlafaxine Preparations Sales Market Share by Type (2021-2032)
  8. 4.3 Global Venlafaxine Preparations Revenue by Type
  9. 4.3.1 Global Venlafaxine Preparations Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Venlafaxine Preparations Revenue by Type (2021-2032)
  11. 4.3.3 Global Venlafaxine Preparations Revenue Market Share by Type (2021-2032)
5 Venlafaxine Preparations Market by Application
  1. 5.1 Venlafaxine Preparations Application Introduction
  2. 5.1.1 Generalized Anxiety Disorder
  3. 5.1.2 Social Anxiety Disorder and Panic Disorder
  4. 5.1.3 Depression
  5. 5.1.4 Other
  6. 5.2 Global Venlafaxine Preparations Sales by Application
  7. 5.2.1 Global Venlafaxine Preparations Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Venlafaxine Preparations Sales by Application (2021-2032)
  9. 5.2.3 Global Venlafaxine Preparations Sales Market Share by Application (2021-2032)
  10. 5.3 Global Venlafaxine Preparations Revenue by Application
  11. 5.3.1 Global Venlafaxine Preparations Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Venlafaxine Preparations Revenue by Application (2021-2032)
  13. 5.3.3 Global Venlafaxine Preparations Revenue Market Share by Application (2021-2032)
6 Global Venlafaxine Preparations Sales by Region
  1. 6.1 Global Venlafaxine Preparations Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Venlafaxine Preparations Sales by Region (2021-2032)
  3. 6.2.1 Global Venlafaxine Preparations Sales by Region (2021-2026)
  4. 6.2.2 Global Venlafaxine Preparations Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Venlafaxine Preparations Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Venlafaxine Preparations Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Venlafaxine Preparations Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Venlafaxine Preparations Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Venlafaxine Preparations Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Venlafaxine Preparations Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Venlafaxine Preparations Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Venlafaxine Preparations Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Venlafaxine Preparations Revenue by Region
  1. 7.1 Global Venlafaxine Preparations Revenue by Region
  2. 7.1.1 Global Venlafaxine Preparations Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Venlafaxine Preparations Revenue by Region (2021-2026)
  4. 7.1.3 Global Venlafaxine Preparations Revenue by Region (2027-2032)
  5. 7.1.4 Global Venlafaxine Preparations Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Venlafaxine Preparations Revenue (2021-2032)
  8. 7.2.2 North America Venlafaxine Preparations Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Venlafaxine Preparations Revenue (2021-2032)
  11. 7.3.2 Europe Venlafaxine Preparations Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Venlafaxine Preparations Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Venlafaxine Preparations Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Venlafaxine Preparations Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Venlafaxine Preparations Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Alembic
  2. 8.1.1 Alembic Company Information
  3. 8.1.2 Alembic Business Overview
  4. 8.1.3 Alembic Venlafaxine Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Alembic Venlafaxine Preparations Product Portfolio
  6. 8.1.5 Alembic Recent Developments
  7. 8.2 Dr. Reddy's Laboratories
  8. 8.2.1 Dr. Reddy's Laboratories Company Information
  9. 8.2.2 Dr. Reddy's Laboratories Business Overview
  10. 8.2.3 Dr. Reddy's Laboratories Venlafaxine Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Dr. Reddy's Laboratories Venlafaxine Preparations Product Portfolio
  12. 8.2.5 Dr. Reddy's Laboratories Recent Developments
  13. 8.3 Granules
  14. 8.3.1 Granules Company Information
  15. 8.3.2 Granules Business Overview
  16. 8.3.3 Granules Venlafaxine Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Granules Venlafaxine Preparations Product Portfolio
  18. 8.3.5 Granules Recent Developments
  19. 8.4 Macleods Pharmaceuticals
  20. 8.4.1 Macleods Pharmaceuticals Company Information
  21. 8.4.2 Macleods Pharmaceuticals Business Overview
  22. 8.4.3 Macleods Pharmaceuticals Venlafaxine Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Macleods Pharmaceuticals Venlafaxine Preparations Product Portfolio
  24. 8.4.5 Macleods Pharmaceuticals Recent Developments
  25. 8.5 Orbion Pharmaceuticals
  26. 8.5.1 Orbion Pharmaceuticals Company Information
  27. 8.5.2 Orbion Pharmaceuticals Business Overview
  28. 8.5.3 Orbion Pharmaceuticals Venlafaxine Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Orbion Pharmaceuticals Venlafaxine Preparations Product Portfolio
  30. 8.5.5 Orbion Pharmaceuticals Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Venlafaxine Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Venlafaxine Preparations Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 Teva
  38. 8.7.1 Teva Company Information
  39. 8.7.2 Teva Business Overview
  40. 8.7.3 Teva Venlafaxine Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Teva Venlafaxine Preparations Product Portfolio
  42. 8.7.5 Teva Recent Developments
  43. 8.8 Zydus
  44. 8.8.1 Zydus Company Information
  45. 8.8.2 Zydus Business Overview
  46. 8.8.3 Zydus Venlafaxine Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Zydus Venlafaxine Preparations Product Portfolio
  48. 8.8.5 Zydus Recent Developments
  49. 8.9 Beijing Foyou Pharma
  50. 8.9.1 Beijing Foyou Pharma Company Information
  51. 8.9.2 Beijing Foyou Pharma Business Overview
  52. 8.9.3 Beijing Foyou Pharma Venlafaxine Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Beijing Foyou Pharma Venlafaxine Preparations Product Portfolio
  54. 8.9.5 Beijing Foyou Pharma Recent Developments
  55. 8.10 Changzhou Siyao Pharmaceuticals
  56. 8.10.1 Changzhou Siyao Pharmaceuticals Company Information
  57. 8.10.2 Changzhou Siyao Pharmaceuticals Business Overview
  58. 8.10.3 Changzhou Siyao Pharmaceuticals Venlafaxine Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Changzhou Siyao Pharmaceuticals Venlafaxine Preparations Product Portfolio
  60. 8.10.5 Changzhou Siyao Pharmaceuticals Recent Developments
  61. 8.11 Chengdu Brilliant Pharmaceutical
  62. 8.11.1 Chengdu Brilliant Pharmaceutical Company Information
  63. 8.11.2 Chengdu Brilliant Pharmaceutical Business Overview
  64. 8.11.3 Chengdu Brilliant Pharmaceutical Venlafaxine Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Chengdu Brilliant Pharmaceutical Venlafaxine Preparations Product Portfolio
  66. 8.11.5 Chengdu Brilliant Pharmaceutical Recent Developments
  67. 8.12 Chengdu Kanghong Pharmaceutical
  68. 8.12.1 Chengdu Kanghong Pharmaceutical Company Information
  69. 8.12.2 Chengdu Kanghong Pharmaceutical Business Overview
  70. 8.12.3 Chengdu Kanghong Pharmaceutical Venlafaxine Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Chengdu Kanghong Pharmaceutical Venlafaxine Preparations Product Portfolio
  72. 8.12.5 Chengdu Kanghong Pharmaceutical Recent Developments
  73. 8.13 ApicHope Pharmaceutical
  74. 8.13.1 ApicHope Pharmaceutical Company Information
  75. 8.13.2 ApicHope Pharmaceutical Business Overview
  76. 8.13.3 ApicHope Pharmaceutical Venlafaxine Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 ApicHope Pharmaceutical Venlafaxine Preparations Product Portfolio
  78. 8.13.5 ApicHope Pharmaceutical Recent Developments
  79. 8.14 Sinopharm Group
  80. 8.14.1 Sinopharm Group Company Information
  81. 8.14.2 Sinopharm Group Business Overview
  82. 8.14.3 Sinopharm Group Venlafaxine Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Sinopharm Group Venlafaxine Preparations Product Portfolio
  84. 8.14.5 Sinopharm Group Recent Developments
  85. 8.15 Hainan Herui Pharmaceutical
  86. 8.15.1 Hainan Herui Pharmaceutical Company Information
  87. 8.15.2 Hainan Herui Pharmaceutical Business Overview
  88. 8.15.3 Hainan Herui Pharmaceutical Venlafaxine Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Hainan Herui Pharmaceutical Venlafaxine Preparations Product Portfolio
  90. 8.15.5 Hainan Herui Pharmaceutical Recent Developments
  91. 8.16 Hefei Lifeon Pharmaceutical
  92. 8.16.1 Hefei Lifeon Pharmaceutical Company Information
  93. 8.16.2 Hefei Lifeon Pharmaceutical Business Overview
  94. 8.16.3 Hefei Lifeon Pharmaceutical Venlafaxine Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Hefei Lifeon Pharmaceutical Venlafaxine Preparations Product Portfolio
  96. 8.16.5 Hefei Lifeon Pharmaceutical Recent Developments
  97. 8.17 Luye Pharma
  98. 8.17.1 Luye Pharma Company Information
  99. 8.17.2 Luye Pharma Business Overview
  100. 8.17.3 Luye Pharma Venlafaxine Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Luye Pharma Venlafaxine Preparations Product Portfolio
  102. 8.17.5 Luye Pharma Recent Developments
  103. 8.18 CSPC Ouyi Pharmaceutical
  104. 8.18.1 CSPC Ouyi Pharmaceutical Company Information
  105. 8.18.2 CSPC Ouyi Pharmaceutical Business Overview
  106. 8.18.3 CSPC Ouyi Pharmaceutical Venlafaxine Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 CSPC Ouyi Pharmaceutical Venlafaxine Preparations Product Portfolio
  108. 8.18.5 CSPC Ouyi Pharmaceutical Recent Developments
  109. 8.19 YaoPharma
  110. 8.19.1 YaoPharma Company Information
  111. 8.19.2 YaoPharma Business Overview
  112. 8.19.3 YaoPharma Venlafaxine Preparations Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 YaoPharma Venlafaxine Preparations Product Portfolio
  114. 8.19.5 YaoPharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Venlafaxine Preparations Value Chain Analysis
  2. 9.1.1 Venlafaxine Preparations Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Venlafaxine Preparations Production Mode & Process
  6. 9.2 Venlafaxine Preparations Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Venlafaxine Preparations Distributors
  9. 9.2.3 Venlafaxine Preparations Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst